{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:30:36Z","timestamp":1780054236464,"version":"3.54.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.amjmed.2012.04.026","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T15:59:05Z","timestamp":1343145545000},"page":"828-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Rare Hematological Adverse Event Induced by Bevacizumab: Severe Thrombocytopenia"],"prefix":"10.1016","volume":"125","author":[{"given":"Marie","family":"Dior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Brezault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Dhooge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Chaussade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2012.04.026_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ejca.2011.03.005","article-title":"Haematologic toxicities associated with the addition of bevacizumab in cancer patients","volume":"47","author":"Schutz","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjmed.2012.04.026_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1634\/theoncologist.2009-0317","article-title":"Bevacizumab","volume":"15","author":"Kazazi-Hyseni","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.amjmed.2012.04.026_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.2011.51","article-title":"Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis","volume":"305","author":"Ranpura","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2012.04.026_bib4","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2012.04.026_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000081006","article-title":"Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis","volume":"67","author":"Koutras","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.amjmed.2012.04.026_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.seminoncol.2003.08.013","article-title":"A phase I\/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer","volume":"30","author":"Cobleigh","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00280-009-1118-2","article-title":"Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report","volume":"65","author":"Leal","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2010-03-276691","article-title":"Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods","volume":"116","author":"Reese","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2012.04.026_bib9","article-title":"Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database","author":"Moulis","year":"2011","journal-title":"Platelets"},{"key":"10.1016\/j.amjmed.2012.04.026_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00280-009-1118-2","article-title":"Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report","volume":"65","author":"Leal","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.20516","article-title":"Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin","volume":"81","author":"Curtis","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib12","first-page":"2","article-title":"Drug-induced immune thrombocytopenia: an overview of pathogenesis","volume":"36","author":"Aster","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2001.19.3.843","article-title":"Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-8722-3-12","article-title":"Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature","volume":"3","author":"Bautista","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib15","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.ejca.2005.06.021","article-title":"Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients","volume":"41","author":"Maindrault-Goebel","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjmed.2012.04.026_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2012.04.026_bib17","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1002625","article-title":"Romiplostim or standard of care in patients with immune thrombocytopenia","volume":"363","author":"Kuter","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2012.04.026_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins\u2014a review of the literature","volume":"38","author":"Kivity","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajh.21060","article-title":"Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients","volume":"83","author":"Spahr","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2012.04.026_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12253-010-9276-4","article-title":"Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma","volume":"17","author":"Demeter","year":"2011","journal-title":"Pathol Oncol Res"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312003506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312003506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:57:53Z","timestamp":1757581073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934312003506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0002934312003506"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.04.026","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Rare Hematological Adverse Event Induced by Bevacizumab: Severe Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}